Respiratorius is a research company. Today, the company is mainly focused on development of new drug candidates for the treatment of chronic obstructive pulmonary disease (COPD), asthma and cancer. Additionally, the company focuses on project development in the area of cardiovascular diseases. The company was formed in 1999 as a spin-off from Lund University. The company is based in Lund.

Quotes for Respiratorius AB

Right Now

+/-
0
%
0,00%
Latest
1.448
High
1.498
Low
1.36
Volume
485 299
Turnover (SEK)
680 537
Value (MSEK)
309,7

Board

CEO

  • Johan Drott

Chairman Of The Board

  • Niklas Prager

Board

  • Anna Törner
  • Ingemar Kihlström
  • Kristina Drott
  • Peter Buhl

Videos